logo
Plus   Neg
Share
Email

Teva Pharmaceutical Industries Limited Q3 adjusted earnings Beat Estimates

Below are the earnings highlights for Teva Pharmaceutical Industries Limited (TEVA):

-Earnings: -$273 million in Q3 vs. $530 million in the same period last year.
-EPS: -$0.27 in Q3 vs. $0.52 in the same period last year.
-Excluding items, Teva Pharmaceutical Industries Limited reported adjusted earnings of $694 million or $0.68 per share for the period.
-Analysts projected $0.54 per share
-Revenue: $4.53 billion in Q3 vs. $5.62 billion in the same period last year.

-Guidance:
Full year EPS guidance: $2.80 - $2.95
Full year revenue guidance: $18.6 - $19.0 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT